cizolirtine has been researched along with Bladder, Overactive in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soljanik, I | 1 |
| Costantini, E; Lazzeri, M | 1 |
| Abadías, M; Brod'ák, M; Pavlík, I; Schraml, P; Sust, M; Villoria, J; Vsetica, J; Zát'ura, F | 1 |
| Bauer, R; May, F | 1 |
| Lazzeri, M | 1 |
| Abadías, M; Arañó, P; Conejero, J; Martínez-García, R; Perales, L; Ruíz, JL; Sust, M | 1 |
2 trial(s) available for cizolirtine and Bladder, Overactive
| Article | Year |
|---|---|
Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
Topics: Adult; Chi-Square Distribution; Confidence Intervals; Czech Republic; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Pyrazoles; Quality of Life; Spain; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2010 |
Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin Gene-Related Peptide; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Middle Aged; Nausea; Pilot Projects; Pyrazoles; Substance P; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics; Vision Disorders; Vomiting; Young Adult | 2009 |
4 other study(ies) available for cizolirtine and Bladder, Overactive
| Article | Year |
|---|---|
Editorial comment on: Cizolirtine citrate is safe and effective to treat urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
Topics: Clinical Trials, Phase II as Topic; Humans; Mandelic Acids; Muscarinic Antagonists; Pyrazoles; Quality of Life; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2010 |
Editorial comment on: Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
Topics: Clinical Trials, Phase II as Topic; Humans; Mandelic Acids; Muscarinic Antagonists; Pyrazoles; Quality of Life; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2010 |
Editorial comment on: Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study.
Topics: Calcitonin Gene-Related Peptide; Female; Humans; Muscarinic Antagonists; Pyrazoles; Substance P; Urinary Bladder, Overactive; Urinary Incontinence | 2009 |
Editorial comment on: Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Aprepitant; Female; Humans; Morpholines; Pyrazoles; Receptors, Neurokinin-1; Thiazoles; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2009 |